
Large-scale enterprise system implementations in regulated pharmaceutical environments require a controlled balance between digital transformation and uninterrupted manufacturing operations. When systems such as SAP are introduced globally across multiple manufacturing sites, the complexity increases significantly due to regulatory obligations, regional operational differences, and the necessity to maintain continuous supply of aseptic medicines.
This case study describes a global SAP implementation project undertaken by an international pharmaceutical manufacturer operating under PIC/S, European Union Good Manufacturing Practice, and United States Food and Drug Administration GMP requirements. The project was executed across Northern and Southern Hemisphere sites, requiring phased deployment while maintaining business as usual manufacturing operations.
Quality Systems Now (QSN) was engaged as part of the project team with responsibility for Quality Management System adaptation, documentation control, training system design, and implementation support across an eighteen-month period.
The manufacturing organisation produced aseptic pharmaceutical products requiring strict environmental control, validated manufacturing processes, and tightly governed quality systems. Any change to enterprise resource planning systems had potential downstream effects on batch release processes, material traceability, deviation management, training records, and regulatory compliance documentation.
The implementation needed to comply with multiple regulatory frameworks simultaneously. PIC/S GMP expectations required consistent inspection readiness across all participating sites. EU GMP introduced stringent requirements for data integrity, electronic system validation, and batch documentation control. FDA GMP expectations reinforced the need for validated systems, audit trails, and controlled documentation practices.
This regulatory environment required that SAP configuration, workflow design, and user access structures were aligned with validated quality systems from the outset.
The global rollout strategy followed a phased geographical sequence. Northern Hemisphere sites were prioritised for initial deployment, followed by Southern Hemisphere implementation once stabilisation activities were complete.
This staggered approach allowed lessons learned from early deployment to be incorporated into subsequent rollouts. However, it also introduced complexity in maintaining harmonised processes across regions operating on different system versions during transition periods.
Manufacturing operations continued throughout the project lifecycle. This required careful coordination between project teams and operational site leadership to ensure that production schedules, quality release activities, and supply chain continuity were not disrupted.
QSN was embedded within the project team structure with defined responsibilities across quality management system adaptation, training development, and change control support. The role required integration with project management governance while maintaining independence in quality oversight activities.
Participation in project planning and reporting ensured that quality considerations were embedded in decision making at an early stage. Regular reporting to the project manager and project board provided visibility of quality risks, document readiness, and training progress across multiple sites.
QSN also acted as a coordination point between global project teams and local site quality functions, ensuring alignment of expectations and consistent application of GMP principles.
A comprehensive gap analysis was conducted on existing site quality management system documentation to identify areas impacted by SAP implementation.
This analysis reviewed procedures related to material management, batch processing records, deviation handling, change control processes, training documentation, and electronic record management. The objective was to determine where procedural updates were required to reflect new system-driven workflows.
Identified gaps were categorised based on risk and regulatory impact. High-priority gaps included changes affecting batch release documentation, electronic signatures, and material traceability processes. Lower-priority gaps included administrative workflow updates and supporting documentation changes.
The output of this analysis formed the basis for controlled document updates across participating sites.
Training was delivered to project team members on structured process mapping techniques to support identification of “As Is” and “To Be” states.
“As Is” mapping documented existing processes within legacy systems and manual workflows. “To Be” mapping defined future-state processes aligned with SAP functionality and integrated quality system requirements.
Local stream leaders were engaged to ensure process mapping reflected actual operational practices rather than theoretical workflows. This approach ensured that system design aligned with real manufacturing and quality control activities.
Process mapping outputs were used to identify procedural changes, system configuration requirements, and training needs across different user groups.
Supporting documentation drafting was undertaken in collaboration with stream teams responsible for specific functional areas such as manufacturing, quality control, warehouse operations, and quality assurance.
QSN provided guidance on GMP-compliant documentation structure, ensuring that revised procedures maintained alignment with regulatory expectations while reflecting new system workflows.
Document updates were controlled through formal change management processes. Each change was assessed for regulatory impact, cross-functional dependencies, and training requirements before approval and implementation.
This controlled approach ensured consistency across multiple sites and prevented uncontrolled divergence between regional documentation sets.
A structured training framework was developed to support SAP implementation across different user access levels. Training packages were tailored to operational roles, ensuring relevance to specific system interactions and responsibilities.
Training content included system navigation, transaction processing, data entry standards, exception handling, and quality system interactions such as deviation initiation and change control workflows.
Training delivery was supported by local stream leads, with QSN providing oversight of training material consistency and alignment with validated processes. Training records were maintained in accordance with GMP requirements to ensure traceability of user competency.
Additional focus was placed on ensuring that training addressed not only system functionality but also the regulatory implications of data entry accuracy, audit trail visibility, and electronic record integrity.
Change management activities were critical to ensuring user adoption and operational continuity. SAP implementation introduced significant changes to established workflows, requiring structured communication and engagement strategies.
QSN supported stakeholder engagement by working directly with local stream leaders to ensure that operational concerns were addressed during system design and rollout planning. This reduced resistance to change and improved alignment between system capabilities and site requirements.
Communication strategies emphasised clarity of impact, timing of changes, and support mechanisms available during transition phases.
Go-live activities were supported through coordinated readiness assessments, final document reviews, and training completion verification. Each site required confirmation that system configuration, documentation updates, and user readiness criteria had been met prior to transition.
During go-live, support mechanisms were in place to address operational issues, clarify procedural questions, and ensure continuity of manufacturing activities. Close monitoring of system performance and user feedback allowed rapid identification of issues requiring resolution.
Post go-live activities included review of system performance, assessment of training effectiveness, and identification of additional procedural refinements required to stabilise operations.
Global SAP implementation within a regulated pharmaceutical environment demonstrates the importance of integrating quality systems, training frameworks, and project governance from the earliest stages of system design.
Successful implementation depends on alignment between technical system configuration and GMP-compliant operational processes. Documentation control, structured training, and controlled change management are essential to maintaining regulatory compliance during transformation.
Phased deployment strategies can support global rollouts, but they require careful management of regional differences and transitional system states. Continuous engagement with site-level stakeholders ensures that system design remains grounded in operational reality.
Ultimately, the success of such a project is determined not only by technical system deployment but also by the ability to maintain product quality, regulatory compliance, and operational continuity throughout the transformation lifecycle.